Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1

被引:83
作者
Naghavi, MH
Schwartz, S
Sönnerborg, A
Vahlne, A
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol Pathol & Infect Dis, Div Clin Virol, S-14186 Huddinge, Sweden
[2] Univ Uppsala, BMC, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol Pathol & Infect Dis, Div Infect Dis, S-14186 Huddinge, Sweden
关键词
D O I
10.1089/088922299310197
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transcription of the HIV-1 provirus genome is regulated by a complex interplay between viral regulatory proteins and cellular transcription factors that interact with the viral long terminal repeat (LTR) region of HIV-1, However, several cellular transcription factors have been identified that can interact with the HIV-1 LTR; the significance of all of these factors is not clearly understood. In this study we have characterized the LTR region of different subtypes of HIV-1 with regard to nucleotide sequence and promoter activity. The LTR regions of HIV-1 from peripheral blood mononuclear cells of 29 infected individuals originating from 10 different geographical regions were sequenced and further analyzed for promoter/enhancer activity in transient transfection of HeLa cells, in the context of a reporter gene and in the context of the complete virus genome. We found several subtype-specific LTR sequences of the various HIV-1 strains, such as an insertion that created a potential third NF-kappa B site in the LTR of the subtype C strains. The USF-binding site in the NRE also contained subtype-specific sequences. Interestingly, the promoter/enhancer activities of the subtype C LTRs were higher than the activities of the other subtypes analyzed here (subtypes A, B, D, E, and G), suggesting that the potential third NF-kappa B site may confer higher LTR activity or that the subtype C NRE may be less potent. Thus, our data suggest that genetic diversity of the LTR may result in HIV-1 subtypes with different replicative properties.
引用
收藏
页码:1293 / 1303
页数:11
相关论文
共 44 条
[21]   IDENTIFICATION OF CIS-ACTING REPRESSIVE SEQUENCES WITHIN THE NEGATIVE REGULATORY ELEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
LU, YC ;
TOUZJIAN, N ;
STENZEL, M ;
DORFMAN, T ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (10) :5226-5229
[22]  
MCCUTCHAN F, 1996, AIDS S, V10, P13
[23]   TEMPORAL FLUCTUATIONS IN HIV QUASISPECIES INVIVO ARE NOT REFLECTED BY SEQUENTIAL HIV ISOLATIONS [J].
MEYERHANS, A ;
CHEYNIER, R ;
ALBERT, J ;
SETH, M ;
KWOK, S ;
SNINSKY, J ;
MORFELDTMANSON, L ;
ASJO, B ;
WAINHOBSON, S .
CELL, 1989, 58 (05) :901-910
[24]   Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes [J].
Montano, MA ;
Novitsky, VA ;
Blackard, JT ;
Cho, NL ;
Katzenstein, DA ;
Essex, M .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8657-8665
[25]   Dysregulation through the NF-ΚB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter [J].
Montano, MA ;
Nixon, CP ;
Essex, M .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8446-8452
[26]   DIFFERENTIAL ROLE OF LONG TERMINAL REPEAT CONTROL ELEMENTS FOR THE REGULATION OF BASAL AND TAT-MEDIATED TRANSCRIPTION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS IN STIMULATED AND UNSTIMULATED PRIMARY HUMAN MACROPHAGES [J].
MOSES, AV ;
IBANEZ, C ;
GAYNOR, R ;
GHAZAL, P ;
NELSON, JA .
JOURNAL OF VIROLOGY, 1994, 68 (01) :298-307
[27]  
MYERS G, 1995, HUMAN RETROVIRUSES A
[28]   AN INDUCIBLE TRANSCRIPTION FACTOR ACTIVATES EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN T-CELLS [J].
NABEL, G ;
BALTIMORE, D .
NATURE, 1987, 326 (6114) :711-713
[29]   DNA sequence of the long terminal repeat of human immunodeficiency virus type I subtype A through G [J].
Naghavi, MH ;
Salminen, MO ;
Sönnerborg, A ;
Vahlne, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (05) :485-488
[30]   CONTRIBUTION OF THE TATA MOTIF TO TAT-MEDIATED TRANSCRIPTIONAL ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS GENE-EXPRESSION [J].
OLSEN, HS ;
ROSEN, CA .
JOURNAL OF VIROLOGY, 1992, 66 (09) :5594-5597